![]()
|
|
||||||||
J. Biol. Chem., Vol. 259, Issue 6, 3387-3390, 03, 1984
SI Chavin and SM Weidner
Enzymatic cleavage of sialic acid from human blood clotting factor IX
results in a loss of factor IX clotting activity. The loss of clotting
activity and the rate of release of sialic acid follow the same time
courses. Control experiments have ruled out several explanations for the
loss of factor IX activity: proteolytic degradation, inhibitory effects of
free sialic acid, and non-specific inhibition of the clotting assays.
Furthermore, no inhibition was seen when similar enzymatic cleavage was
carried out on factor X and factor VIII. Therefore, we suggest that the
loss of factor IX activity is the direct result of cleavage of sialic acid
from the protein. Most of the inhibition appeared to be an effect on the
activity of factor IXa itself, and thus far, little or no effect has been
shown on the activation of factor IX to IXa. The structural basis for this
unusual effect of sialic acid on protein function currently is being
investigated.
Blood clotting factor IX. Loss of activity after cleavage of sialic acid residues
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. Bharadwaj, R. J. Harris, W. Kisiel, and K. J. Smith Enzymatic Removal of Sialic Acid from Human Factor IX and Factor X Has No Effect on Their Coagulant Activity J. Biol. Chem., March 24, 1995; 270(12): 6537 - 6542. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |